Skip to main content
SpringerLink
Log in
Book cover

Fettstoffwechsel pp 301–316Cite as

Type III-Hyperlipoproteinemia

  • Chapter

Part of the book series: Handbuch der inneren Medizin ((INNEREN 7,volume 7 / 4))

Abstract

Familial type III hyperlipoproteinemia (synonyms: “floating beta” disorder, familial “broad beta” disease, dysbetalipoproteinemia) is an uncommon genetically determined disorder of lipoprotein metabolism (Fredrickson et al., 1967; Quartfordt et al., 1971; Hazzard et al., 1972; Fredrickson and Levy, 1972). The exact metabolic defect and genetic mode of inheritance are not yet established. It is characterized by an apparent abnormal lipoprotein form, elevation in plasma cholesterol and triglyceride levels, typical cutaneous and subcutaneous lesions and premature peripheral and coronary vessel disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Assmann, G., Krauss, R.M., Fredrickson, D.S., Levy, R.I.: Characterization, subcellular localization and partial purification of a heparin-released triglyceride-lipase from rat liver. J. biol. Chem. 248, March (1973).

    Google Scholar 

  • Baes, H., Gent, C.M., Van Pries, C.: Lipid composition of various types of xanthoma. J. invest. Derm. 51, 280–293 (1968).

    Google Scholar 

  • Bartter, P.J., Nestel, P.J.: The distribution of triglyceride in subclasses of very low density plasma lipoproteins. J. Lab. clin. Med. 76, 925–932 (1970).

    Google Scholar 

  • Bartter, P.J., Nestel, P.J.: Precursor-product relationship between pools of very low density lipoprotein triglyceride. J. clin. Invest. 51, 174–180 (1972).

    Article  Google Scholar 

  • Beaumont, S.L., Jacotot, B., Beaumont, V.: L’hyperlipidemie par autoanticorps une diabetic ketoacidosis cause d’atherosclerose. Presse Med. 75, 2315 (1967).

    PubMed  CAS  Google Scholar 

  • Bilheimer, D.W., Eisenberg, S., Levy, R.I.: Abnormal metabolism of very low density lipoproteins (VLDL) in type III hyperlipoproteinemia (type III). Circulation 2, 56 (1971).

    Google Scholar 

  • Bilheimer, D.W., Eisenberg, S., Levy, R.I.: Human plasma very low density lipoprotein metabolism. J. clin. Invest. 50, 8a (1971).

    Google Scholar 

  • Bilheimer, D.W., Eisenberg, S., Levy, R.I.: The metabolism of very low density lipoprotein proteins. 1. Preliminary in vitro and in vivo observations. Biochim. biophys. Acta (Amst.) 260, 212–221 (1972).

    CAS  Google Scholar 

  • Blanchette-Mackie, E.J., Scow, R.O.: Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons. Electron microscope cytochemical study. J. Cell Biol. 51, 1–25 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Borrie, P.: Essential hyperlipaemia and idiopathic hypercholesterolaemic xanthomatosis. Brit. med. J. 1957 II, 911–915.

    Article  Google Scholar 

  • Borrie, P.: Type III hyperlipoproteinemia. Brit. Med. J. 1969 II, 665–667.

    Article  Google Scholar 

  • Brown, W.V., Levy, R.I., Fredrickson, D.S.: Studies of the proteins in human plasma very low density lipoproteins. J. biol. Chem. 244, 5687–5694 (1969).

    PubMed  CAS  Google Scholar 

  • Brown, W.V., Levy, R.I., Fredrickson, D.S.: Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim. biophys. Acta (Amst.) 200, 573–575 (1970).

    CAS  Google Scholar 

  • Brown, W.V., Levy, R.I., Fredrickson, D.S.: Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J. biol. Chem. 245, 6588–6594 (1970).

    PubMed  CAS  Google Scholar 

  • Bungenberg de Jong, J.J., Marsh, J.B.: Biosynthesis of plasma lipoproteins by rat liver ribosomes. J. biol. Chem. 243, 192–199 (1968).

    CAS  Google Scholar 

  • Eisenberg, S., Bilheimer, D.W., Levy, R.I.: The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoprotein. Biochim. biophys. Acta (Amst.) 280, 94–104 (1972).

    CAS  Google Scholar 

  • Eisenberg, S., Bilheimer, D.W., Lindgren, F.T., Levy, R.I.: On the apoprotein composition of human plasma very low density lipoprotein subfractions. Biochim. biophys. Acta (Amst.) 260, 329–333 (1972).

    CAS  Google Scholar 

  • Eisenberg, S., Bilheimer, D.W., Levy, R.I., Lindgren, F.T.: On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim. Biophys. Acta (Amst.) 326, 361–377 (1973).

    CAS  Google Scholar 

  • Farquhar, J.W., Gross, R.C., Wagner, R.M., Reaven, H.M.: Validation of an incompletely coupled two-compartment nonrecycling catenary model for turnover of liver and plasma triglyceride in man. J. Lipid Res. 6, 119–134 (1965).

    PubMed  CAS  Google Scholar 

  • Feiwel, M.: Xanthomatosis in cryoglobulinemia and other paraproteinaemias with report of a case. Brit. J. Derm. 80, 719–729 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Fredrickson, D.S., Levy, R.I.: Familial hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease. (Ed. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S.), 3rd Ed. p. 545. New York: McGraw-Hill 1972.

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Jones, E., Bonnell, M., Ernst, N.: The Dietary Management of Hyperlipoproteinemia: A Handbook for Physicians. Washington: U.S. Department of Health, Education and Welfare, Public Health Service 1970.

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 34–44, 94–103, 148–156, 215–224, 273–281 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lindgren, F.T.: A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J. clin. Invest. 47, 2446–2457 (1968).

    Article  CAS  Google Scholar 

  • Gitlin, D., Cornwell, D.G., Nakasato, D., Oncley, F.L., Hughes, W.L., Jr., Janeway, C.A.: Studies on the metabolism of plasma proteins in the nephrotic syndrome II. The Lipoproteins. J. clin. Invest. 37, 172–184 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Glueck, C.J., Levy, R.I., Fredrickson, D.S.: Immunoreactive insulin, glucose tolerance, and carbohydrate: Inducibility in types II, III, IV and V hyperlipoproteinemia. Diabetes 18, 739–747 (1969).

    PubMed  CAS  Google Scholar 

  • Godolphin, W.J., Conradi, G., Campbell, D.I.: Type III Hyperlipoproteinemia in a child. Lancet 1972 I, 209–210.

    Article  Google Scholar 

  • Gofman, J.W., De Lalle, O., Glazier, F., Freeman, N.K., Lindgren, F.T., Nichols, A.D., Strishower, E.H., Tamplin, A.R.: The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. Plasma 2, 413 (1954).

    Google Scholar 

  • Gofman, J.W., Rubin, L., McGinley, J.P., Jones, H.B.: Hyperlipoproteinemia. Amer. J. Med. 17, 514 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Gotto, A.M., Brown, W.D., Levy, R.I., Birnbauber, M.E., Fredrickson, D.S.: Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J. clin. Invest. 51, 1486–1494 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Hazzard, W.R., Bierman, E.L.: Impaired removal of very low density lipoprotein (VLDL) “Remnants” in the pathogenesis of broad β disease (type III hyperlipoproteinemia). Clin. Res. 19, 476 (1971).

    Google Scholar 

  • Hazzard, W.R., Bierman, E.L.: Aggravation of broad-β disease (type 3 hyperlipoproteinemia) by hypothyroidism. Arch. intern. Med. 130, 822–828 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Hazzard, W.R., Lindgren, F.T., Bierman, E.L.: Very low density lipoprotein subfractions in a subject with broad β disease (type III hyperlipoproteinemia) and a subject with endogenous lipemia (type IV). Chemical composition and electrophoretic mobility. Biochim. biophys. Acta (Amst.) 202, 517–525 (1970).

    CAS  Google Scholar 

  • Hazzard, W.R., Porte, D., Jr., Bierman, E.L.: Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type III hyperlipoproteinemia). Metabolism 21, 1009–1019 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Herbert, P., Levy, R.I., Fredrickson, D.S.: Correction of COOH-terminal amino acids of human plasma very low density apolipoproteins. J. biol. Chem. 246, 7068–7071 (1971).

    PubMed  CAS  Google Scholar 

  • Jepson, E.M., Billimoria, J.D., Maclagan, N.F.: Serum and tissue lipids in patients with familial xanthomatosis. Clin. Sci. 29, 383–390 (1965).

    PubMed  CAS  Google Scholar 

  • Langer, T., Strober, W., Levy, R.I.: The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J. clin. Invest. 5, 1528–1536 (1972).

    Article  Google Scholar 

  • Lever, W.F., Smith, P.A.J., Hurley, N.A.: Idiopathic hyperlipemic and primary hypercholesteremic xanthomatosis. I. Clinical data and analysis of the plasma lipids. J. invest. Derm. 22, 33–51 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Levy, R.I., Bilheimer, D.W., Eisenberg, S.: The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL), in plasma lipoproteins. Biochemical Society Symposia No. 33 (Ed. Smellie, R.M.S.), p. 3–17. London and New York: Academic Press 1971.

    Google Scholar 

  • Levy, R.I., Bonnell, M., Ernst, N.D.: Dietary management of hyperlipoproteinemia. J. Amer. diet. Ass. 58, 406–416 (1971).

    PubMed  CAS  Google Scholar 

  • Levy, R.I., Fredrickson, D.S.: The current status of hypolipidemic drugs. Postgrad. Med. 47, 130–136 (1970).

    PubMed  CAS  Google Scholar 

  • Levy, R.I., Fredrickson, D.S., Shulman, R., Bilheimer, D.W., Breslow, J.L., Stone, N.J., Lux, S.E., Sloan, H.R., Krauss, R.M., Herbert, P.N.: Dietary and drug treatment of primary hyperlipoproteinemia. Ann. intern. Med. 77, 267–294 (1972).

    CAS  Google Scholar 

  • Levy, R.I., Quarfordt, S.H., Brown, W.D., Sloan, H.R., Fredrickson, D.S.: In: Drugs Affecting Lipid Metabolism (Ed. Holmes, W.L., Carlson, L.A., Paoletti, R.), p. 377. New York: Plenum Press 1969. [Proceedings of the Third International Symposium on Drugs Affecting Lipid Metabolism, Milan, Italy, Sept. 8–11 (1968)].

    Google Scholar 

  • Masket, B.H., Levy, R.I., Fredrickson, D.S.: The use of Polyacrylamide gel electrophoresis in differentiating type III hyperlipoproteinemia. J. Lab. clin. Med. 81, 794–802 (1973).

    PubMed  CAS  Google Scholar 

  • Matthews, R.J.: Type III and IV familial hyperlipoproteinemia, evidence that these two syndromes are different phenotypic expressions of the same mutant gene(s). Amer. J. Med. 44, 188–199 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Morganroth, J., Levy, R.I., Fredrickson, D.S.: The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann. Intern. Med. 82, 158–174 (1975).

    PubMed  CAS  Google Scholar 

  • Nevin, N.C., Slack, J.: Hyperlipidaemic xanthomatosis II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis. J. med. Genet. 5, 9–28 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Quarfordt, S.H., Frank, A., Shames, D.M., Berman, M., Steinberg, D.: Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J. clin. Invest. 49, 2281–2297 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Quarfordt, S.H., Levy, R.I., Fredrickson, D.S.: On the lipoprotein abnormality in type III hyperlipoproteinemia. J. clin. Invest. 50, 754–761 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Quarfordt, S.H., Levy, R.I., Fredrickson, D.S.: The kinetic properties of type III very low density lipoprotein triglyceride. Biochim. biophys. Acta (Amst.) 296, 572–576 (1973).

    CAS  Google Scholar 

  • Redman, C.M.: The synthesis of serum proteins on attached rather than free ribosomes of rat liver. Biochim. biophys. Res. Commun. 31, 845–850 (1968).

    Article  CAS  Google Scholar 

  • Redgrave, T.G.: Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. clin. Invest. 49, 465–471 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Retcher, R.F., Gloster, J.: The lipids in xanthomata. J. clin. Invest. 43, 2104–2111 (1964).

    Article  Google Scholar 

  • Roberts, W.C., Ferrans, D.J., Levy, R.I., Fredrickson, D.S.: Cardiovascular pathology in hyperlipoproteinemia. Amer. J. Cardiol. 31, 557–570 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Roberts, W.C., Levy, R.I., Fredrickson, D.S.: Hyperlipoproteinemia: A review of the five types with first report of necropsy findings in type 3. Arch. Path. 90, 46–56 (1970).

    PubMed  CAS  Google Scholar 

  • Sata, T., Havel, R.I., Jones, A.L.: Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normalipemic and hyperlipemic humans. J. Lipid Res. 13, 757–768 (1972).

    PubMed  CAS  Google Scholar 

  • Shore, B., Shore, D.: Isolation and characterization of polypeptides of human serum lipoproteins. Biochemistry 8, 4510–4516 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Stern, M.P., Kolkmann, O.G., Mc Devitt, H., Reaven, G. M.: Acquired type III hyperlipoproteinemia. Report of three cases associated with systemic lupus erythematosus. Arch, intern. Med. 130, 817–821 (1972).

    Article  CAS  Google Scholar 

  • Strisower, E.H., Adamson, G., Strisower, B.: Treatment of hyperlipidemias. Amer. J. Med. 45, 488–501 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Walker, A.E., Sneddon, I.B.: Skin xanthoma following erythroderma. Brit. J. Derm. 80, 580–587 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Wilson, J.D.: Studies on the origin of the lipid components of xanthomata. Circulat. Res. 12, 472–478 (1963).

    CAS  Google Scholar 

  • Wilson, D.E., Lees, R.S.: Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J. clin. Invest. 51, 1051–1057 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Zelis, R., Mason, D.T., Braunwald, E., Levy, R.I.: Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J. clin. Invest. 49, 1007–1015 (1970).

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. I. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Klinische Chemie der Universitätskliniken, Joseph-Stelzmann-Straße 9, D-5000, Köln 41, Deutschland

    G. Assmann

  2. Klinisches Institut für Herzinfarktforschung, Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    J. Augustin , H. Greten , G. Middelhoff  & G. Schlierf , ,  & 

  3. Section and Laboratory of Liver Diseases, Nutrition and Alcoholism, Veterans Administration Hospital, 130 West Kingsbridge Road, Bronx, N.Y., 10468, USA

    E. Baraona  & C. S. Lieber  & 

  4. Mt. Sinai School of Medicine(CUNY), New York, N.Y., USA

    E. Baraona  & C. S. Lieber  & 

  5. Institut für Hirnforschung der Universität, Belthlestraße 15, D-7400, Tübingen, Deutschland

    H. U. Benz  & K. Harzer  & 

  6. Internistische Germeinschaftspraxis, Dialyse-Institut, Werastraße 33, D-7990, Friedrichshafen, Deutschland

    W. Brech

  7. Division of Metabolic Disease, Department of Medicine, School of Medicine, University of California, La Jolla, California, 92037, USA

    W. V. Brown

  8. Departments of Pediatrics, Genetics and Cell Biology and The Dight Institute of Human Genetics, University of Minnesota, Box 231, Mayo Memorial Building, Minneapolis, Minnesota, 55455, USA

    R. J. Desnick

  9. Department of Internal Medicine, College of Medicine, Lipid Research Clinic, University of Cincinnati Medical Center, 234 Goodman Street, Cincinnati, Ohio, 45229, USA

    W. R. Fallat

  10. Lipid Research Center, University of Cincinnati, Cincinnati, Ohio, 45229, USA

    S. Ford  & Ch. J. Glueck  & 

  11. General Clinical Research Center, University of Cincinnati, Cincinnati, Ohio, 45229, USA

    S. Ford  & Ch. J. Glueck  & 

  12. National Institutes of Health, Bethesda, Maryland, 20014, USA

    D. Fredrickson

  13. Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, 20014, USA

    P. Herbert  & R. I. Levy  & 

  14. Institut für Medizinische Biochemie der Universitä, Harrachgasse 21, A-8010, Graz, Öterreich

    G. M. Kostner

  15. Department of Pediatrics, University of Minnesota, Box 231, Mayo Memorial Building, Minneaplis, Minnesota, 55455, USA

    W. Krivit

  16. Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    M. Liersch , G. Schettler , E. Stange  & A. Weizel , ,  & 

  17. Courtauld Institute of Biochemistry, Middlesex Hospital Medical School, London W 1, England

    G. L. Mills

  18. Medical Research Council Lipid Metabolism Unit, Hammersmith Hospital, Ducane Road, London, W12 OHS, England

    N. B. Myant  & J. Slack  & 

  19. Departments of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, 55455, USA

    R. F. O’Dea

  20. Research Associate in the Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland, 20014, USA

    R. F. O’Dea

  21. Innere Abteilung, Knappschafts-Krankenhaus, Am Deimelsberg 34a, 4300, Essen-Steele, Deutschland

    J. Papenberg

  22. Neurologische Klinik und Poliklinik der Universität, v. Siebold-Straße 5, D-3400, Göttingen, Deutschland

    H. Pilz

  23. Schierghoferstraße 24a, D-8220, Traunstein/Obb, Deutschland

    H. M. Rauen

  24. Medizinische Universitätsklinik, Anich-Straße 35, A-6020, Innsbruck, Austria

    S. Sailer

  25. Abteilung für Experimentlle Zellforschung, Physiologisch-Chemisches Institute der Universität, Waldeyerstraße 15, D-4400, Münster/Westf, Deutschland

    H. Schriewer

  26. Klinisch-Chemisches Laboratorium, Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    D. Seidel  & H. Wieland  & 

  27. Department of Experimental Medicine and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel

    O. Stein

  28. Lipid Research Laboratory, Department of Medicine B, Hadassah University Hospital, Jerusalem, Israel

    Y. Stein

  29. Division of Metabolic Disease, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, 92093, USA

    D. Steinberg

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Levy, R.I., Assmann, G. (1976). Type III-Hyperlipoproteinemia. In: Assmann, G., et al. Fettstoffwechsel. Handbuch der inneren Medizin, vol 7 / 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66302-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66302-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66303-1

  • Online ISBN: 978-3-642-66302-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation